Abstract
THE antibiotic bleomycin is effective against certain human neoplastic diseases1. Interaction of purified DNA with bleomycin results in the release of free bases from the DNA backbone2,3, disruption of phosphodiester linkage, and destruction of the deoxyribose moiety4. Bleomycin-induced DNA strand scissions, both single- and double-strand, were found in bacterial as well as in mammalian systems5,6. But, all previous work on bleomycin has dealt with DNA molecules extracted from treated cells, and analysed on sucrose density gradients. This is not sensitive enough to probe the action of bleomycin with respect to chromatin structure. It is now known that chromatin is composed of a number of repeating subunits connected by a continuing DNA duplex analogous to ‘beads on a string’7. The bead-like structure, termed nucleosome or nu-body, contains 140 base pairs and eight histone molecules8,9. The DNA between nucleosomes, about 40–60 base pairs in length, is referred to as the linker DNA. Both DNAs in the nucleosomes and in the linker are susceptible to nuclease digestion, but the latter is more sensitive10–12. We have analysed the effects of bleomycin on chromatin with special reference to the characterisation of the breakage sites in a number of mammalian cell systems. The results reported here indicate that bleomycin is one of the few non-enzymatic chemicals which can be used to study the chromatin structure, and that the action of bleomycin is not identical to that of nucleases—bleomycin does not digest nucleosome DNA but attacks only the linker DNA.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Blum, R. H., Carter, S. K. & Agre, K. Cancer 31, 903–914 (1977).
Haidle, C. W., Weiss, K. K. & Kuo, M. T. Molec. Pharmac. 8, 531–537 (1972).
Muller, W. E. G., Yamazaki, Z-I., Breter, H. J. & Zahn, R. K. Eur. J. Biochem. 31, 518–525 (1972).
Kuo, M. T. & Haidle, C. W. Biochim. biophys. Acta 335, 109–114 (1973).
Suzuki, H., Nagai, K., Akutzu, E., Yamaki, H., Tanaka, N. & Umezawa, H. J. Antibiot. 23, 473–480 (1970).
Terasima, T., Yasukawa, M. & Umezawa, H. Gann 61, 513–516 (1970).
Olins, A. L. & Olins, D. E. Science 183, 330–332 (1974).
Kornberg, R. D. Science 184, 868–871 (1974).
Simpson, R. T. & Bustin, M. Biochemistry 15, 4305–4312 (1976).
Sollner-Webb, B. & Felsenfeld, G. Biochemistry 14, 2915–2920 (1975).
Shaw, B. R., Herman, T. M., Kovacic, R. T., Beaudreau, G. S. & Van Holde, K. E. Proc. natn. Acad. Sci. U.S.A. 73, 505–509 (1976).
Axel, R. Biochemistry 14, 2921–2925 (1975).
Rill, R. L., Nelson, D. A., Oosterhof, D. K. & Hozier, J. C. Nucleic Acid Res. 4, 771–789 (1977).
Compton, J. L., Bellard, M. & Chambon, P. Proc. natn. Acad. Sci. U.S.A. 73, 4382–4386 (1976).
Noll, M. Nucleic Acid Res. 1, 1573–1578 (1974).
Whitlock, J. P. Jr, Rushizky, G. W. & Simpson, R. T. J. biol. Chem. 252, 3003–3006 (1976).
Sollner–Webb, B. & Felsenfeld, G. Cell 10, 537–547 (1977).
Kuo, M. T., Haidle, C. W. & Inners, L. D. Biophys. J. 13, 1295–1306 (1973).
Crick, F. M. & Klug, A. Nature 255, 530–533 (1975).
Kuo, M. T., Sahasrabuddhe, C. G. & Saunders, G. F. Proc. natn. Acad. Sci. U.S.A. 73, 1572–1575 (1976).
Maniatis, T., Jeffrey, A. & Van de Sande, H. Biochemistry 14, 3787–3794 (1975).
Brack, C., Eberle, M., Bickle, T. A. & Yuan, R. J. molec. Biol. 104, 305–309 (1976).
Kovacic, R. T. & Van Holde, K. E. Biochemistry 16, 1490–1498 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kuo, M., Hsu, T. Bleomycin causes release of nucleosomes from chromatin and chromosomes. Nature 271, 83–84 (1978). https://doi.org/10.1038/271083a0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/271083a0
This article is cited by
-
The DNA sequence specificity of bleomycin cleavage in a systematically altered DNA sequence
JBIC Journal of Biological Inorganic Chemistry (2017)
-
The genome-wide DNA sequence specificity of the anti-tumour drug bleomycin in human cells
Molecular Biology Reports (2016)
-
The determination of the DNA sequence specificity of bleomycin-induced abasic sites
JBIC Journal of Biological Inorganic Chemistry (2016)
-
The anti-tumor drug bleomycin preferentially cleaves at the transcription start sites of actively transcribed genes in human cells
Cellular and Molecular Life Sciences (2014)
-
Bleomycins: towards better therapeutics
Nature Reviews Cancer (2005)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.